Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Seiler

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
World Journal of Urology|September 22, 2018
Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversionOscar Rodríguez Faba, Mark D Tyson, Walter Artibani, et al.
Urologic Oncology|November 13, 2017
Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the futureTom J N Hermans, Charlotte S Voskuilen, Michiel S van der Heijden, et al.
European Urology|March 31, 2021
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant PembrolizumabAndrea Necchi, Joep J de Jong, Daniele Raggi, et al.
Scientific Reports|February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapyBernhard Kiss, Alexander W Wyatt, James Douglas, et al.
NPJ Precision Oncology|April 18, 2026
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategiesRiccardo Bevilacqua, Paola Gasperini, Thomas Cantore, et al.
Urologic Oncology|July 31, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|October 6, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Swiss Medical Weekly|September 8, 2021
Swiss germ-cell cancer consensus recommendationsJörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
Nature Communications|April 18, 2023
Bladder cancer organoids as a functional system to model different disease stages and therapy responseMartina Minoli, Thomas Cantore, Daniel Hanhart, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
World Journal of Urology|September 22, 2018
Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversionOscar Rodríguez Faba, Mark D Tyson, Walter Artibani, et al.
Urologic Oncology|November 13, 2017
Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the futureTom J N Hermans, Charlotte S Voskuilen, Michiel S van der Heijden, et al.
European Urology|March 31, 2021
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant PembrolizumabAndrea Necchi, Joep J de Jong, Daniele Raggi, et al.
Scientific Reports|February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapyBernhard Kiss, Alexander W Wyatt, James Douglas, et al.
NPJ Precision Oncology|April 18, 2026
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategiesRiccardo Bevilacqua, Paola Gasperini, Thomas Cantore, et al.
Urologic Oncology|July 31, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|October 6, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Swiss Medical Weekly|September 8, 2021
Swiss germ-cell cancer consensus recommendationsJörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
Nature Communications|April 18, 2023
Bladder cancer organoids as a functional system to model different disease stages and therapy responseMartina Minoli, Thomas Cantore, Daniel Hanhart, et al.
Pageof 14